Literature DB >> 7539545

Cytokine production and serum proteins in depression.

A Seidel1, V Arolt, M Hunstiger, L Rink, A Behnisch, H Kirchner.   

Abstract

One, as yet unemployed, approach to investigating immunology in depression is the assessment of the cytokine production by leucocytes, which would allow the determination of immune response under standardized conditions. Thus we measured the production of mitogen-induced cytokines (IL-1 beta, IL-2, IL-6, IL-10, interferon-gamma) and sIL-2R in a whole blood assay, and serum protein levels such as C-reactive protein (CRP), haptoglobin (Hp) and alpha 2-macroglobulin (alpha 2 M) in a longitudinal 6-week study in an attempt to assess leucocyte function during and after acute clinical stage of depression in 39 patients. Shortly after admission to hospital we found higher levels of all measured cytokines in the patients. Serum protein levels were significantly higher in the patients than in controls, and decreased over the study period. Whereas slightly elevated monokine levels in patients tended to reach control values, lymphokines showed a significant decrease over the 6 weeks as compared to baseline. These results suggest that the increase in immune activity seen at the beginning of the study may be followed by a suppressed cell-mediated immune function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539545     DOI: 10.1111/j.1365-3083.1995.tb03604.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  39 in total

Review 1.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

2.  Immune system dysregulation in adolescent major depressive disorder.

Authors:  Vilma Gabbay; Rachel G Klein; Carmen M Alonso; James S Babb; Melissa Nishawala; Georgette De Jesus; Glenn S Hirsch; Pauline M Z Hottinger-Blanc; Charles J Gonzalez
Journal:  J Affect Disord       Date:  2008-09-13       Impact factor: 4.839

3.  Distinct inflammatory response patterns are evident among men and women with higher depressive symptoms.

Authors:  Marzieh Majd; Jennifer E Graham-Engeland; Joshua M Smyth; Martin J Sliwinski; Richard B Lipton; Mindy J Katz; Christopher G Engeland
Journal:  Physiol Behav       Date:  2017-11-10

4.  Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial.

Authors:  André R Brunoni; Rodrigo Machado-Vieira; Carlos A Zarate; Leandro Valiengo; Erica Lm Vieira; Isabela M Benseñor; Paulo A Lotufo; Wagner F Gattaz; Antonio L Teixeira
Journal:  Psychopharmacology (Berl)       Date:  2013-10-23       Impact factor: 4.530

5.  Interleukin-6 and memory functions of encoding and recall in healthy and depressed elderly adults.

Authors:  Virginia Elderkin-Thompson; Michael R Irwin; Gerhard Hellemann; Anand Kumar
Journal:  Am J Geriatr Psychiatry       Date:  2012-09       Impact factor: 4.105

6.  Effects of salicylate on the inflammatory genes expression and synaptic ultrastructure in the cochlear nucleus of rats.

Authors:  Shou-Sen Hu; Ling Mei; Jian-Yong Chen; Zhi-Wu Huang; Hao Wu
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

Review 7.  Depression and immunity: inflammation and depressive symptoms in multiple sclerosis.

Authors:  Stefan M Gold; Michael R Irwin
Journal:  Immunol Allergy Clin North Am       Date:  2009-05       Impact factor: 3.479

8.  A preliminary study of cytokines in suicidal and nonsuicidal adolescents with major depression.

Authors:  Vilma Gabbay; Rachel G Klein; Leah E Guttman; James S Babb; Carmen M Alonso; Melissa Nishawala; Yisrael Katz; Marta R Gaite; Charles J Gonzalez
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-08       Impact factor: 2.576

Review 9.  [Immunological aspects of depressive disorders].

Authors:  N Müller; M J Schwarz
Journal:  Nervenarzt       Date:  2007-11       Impact factor: 1.214

10.  Polymorphisms in the interleukin-10 gene cluster are possibly involved in the increased risk for major depressive disorder.

Authors:  Tanel Traks; Kati Koido; Triin Eller; Eduard Maron; Külli Kingo; Veiko Vasar; Eero Vasar; Sulev Kõks
Journal:  BMC Med Genet       Date:  2008-12-16       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.